A detailed history of Goldman Sachs Group Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,158,328 shares of TEVA stock, worth $71.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,158,328
Previous 4,290,647 3.08%
Holding current value
$71.2 Million
Previous $69.7 Million 7.47%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $2.09 Million - $2.51 Million
-132,319 Reduced 3.08%
4,158,328 $74.9 Million
Q2 2024

Aug 13, 2024

BUY
$12.78 - $17.4 $9.54 Million - $13 Million
746,787 Added 21.07%
4,290,647 $69.7 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $2.79 Million - $3.77 Million
-261,488 Reduced 6.87%
3,543,860 $50 Million
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $5.15 Million - $6.74 Million
-633,945 Reduced 14.28%
3,805,348 $39.7 Million
Q3 2023

May 14, 2024

BUY
$7.48 - $10.7 $4.74 Million - $6.78 Million
633,945 Added 16.66%
4,439,293 $45.3 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $826,839 - $1.18 Million
-110,540 Reduced 2.43%
4,439,293 $45.3 Million
Q2 2023

May 14, 2024

SELL
$7.2 - $9.47 $758,001 - $996,982
-105,278 Reduced 2.26%
4,549,833 $34.3 Million
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $758,001 - $996,982
-105,278 Reduced 2.26%
4,549,833 $34.3 Million
Q1 2023

May 14, 2024

SELL
$8.36 - $11.37 $5.71 Million - $7.77 Million
-683,033 Reduced 12.8%
4,655,111 $41.2 Million
Q1 2023

May 11, 2023

SELL
$8.36 - $11.37 $5.71 Million - $7.77 Million
-683,033 Reduced 12.8%
4,655,111 $41.2 Million
Q4 2022

May 14, 2024

BUY
$7.95 - $9.48 $945,883 - $1.13 Million
118,979 Added 2.28%
5,338,144 $48.7 Million
Q4 2022

Feb 13, 2023

BUY
$7.95 - $9.48 $945,883 - $1.13 Million
118,979 Added 2.28%
5,338,144 $48.7 Million
Q3 2022

May 14, 2024

BUY
$6.86 - $11.95 $2.75 Million - $4.78 Million
400,197 Added 8.3%
5,219,165 $42.1 Million
Q3 2022

Nov 10, 2022

BUY
$6.86 - $11.95 $2.75 Million - $4.78 Million
400,197 Added 8.3%
5,219,165 $42.1 Million
Q2 2022

May 14, 2024

BUY
$7.38 - $10.4 $7.48 Million - $10.5 Million
1,013,620 Added 26.64%
4,818,968 $36.2 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $10.5 Million - $14.8 Million
1,425,393 Added 42.0%
4,818,968 $36.2 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $5.17 Million - $6.63 Million
-705,599 Reduced 17.21%
3,393,575 $31.9 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $6.62 Million - $8.54 Million
837,955 Added 25.69%
4,099,174 $32.8 Million
Q3 2021

Nov 10, 2021

BUY
$8.38 - $10.18 $27.3 Million - $33.2 Million
3,261,219 New
3,261,219 $31.8 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.